Main Street Financial Solutions’s Royalty Pharma RPRX Stock Holding History

Main Street Financial Solutions’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.83M	Buy	99,185 +4,040	+4%	+$154K	0.29%	76
2025 Q3	$3.36M	Sell	95,145 -16,740	-15%	-$606K	0.22%	102
2025 Q2	$4.03M	Buy	111,885 +31,844	+40%	+$1.06M	0.29%	74
2025 Q1	$2.49M	Buy	+80,041	New	+$2.54M	0.22%	105
2024 Q4	–	Sell	-80,081	Closed	-$2.27M	–	555
2024 Q3	$2.27M	Buy	80,081 +34,611	+76%	+$959K	0.21%	98
2024 Q2	$1.2M	Buy	+45,470	New	+$1.26M	0.11%	167

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Main Street Financial Solutions's RPRX Position: Q4 2025 in Review

Main Street Financial Solutions increased its Royalty Pharma (RPRX) stake by 4.2% in Q4 2025, buying an estimated $154K and bringing the position to 99,185 shares worth $3.83M. The position accounts for 0.29% of the portfolio, ranked #76.

Main Street Financial Solutions first reported a position in RPRX in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.03M in Q2 2025. 538 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

Main Street Financial Solutions held 99,185 shares of Royalty Pharma worth $3.83M as of Q4 2025.
Main Street Financial Solutions bought 4,040 Royalty Pharma shares in Q4 2025, an estimated $154K.
Royalty Pharma made up 0.29% of Main Street Financial Solutions's portfolio in Q4 2025, its #76 holding.
Main Street Financial Solutions first reported a position in Royalty Pharma in Q2 2024 and has held it in 6 quarters since.
Main Street Financial Solutions's Royalty Pharma position peaked at $4.03M in Q2 2025.
538 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on Main Street Financial Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.